Biopharmaceuticals VS BRANDS 6/19/25 Biopharmaceuticals VS BRANDS 6/19/25 PolyActiva Appoints Jerry St. Peter as CEO and Secures $25M Series C Funding for U.S. Expansion and Clinical Development Read More Biopharmaceuticals VS BRANDS 3/24/25 Biopharmaceuticals VS BRANDS 3/24/25 Byondis Appoints Christoph Korpus as Chief Business Officer Read More
Biopharmaceuticals VS BRANDS 6/19/25 Biopharmaceuticals VS BRANDS 6/19/25 PolyActiva Appoints Jerry St. Peter as CEO and Secures $25M Series C Funding for U.S. Expansion and Clinical Development Read More
Biopharmaceuticals VS BRANDS 3/24/25 Biopharmaceuticals VS BRANDS 3/24/25 Byondis Appoints Christoph Korpus as Chief Business Officer Read More
